{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:58:25Z","timestamp":1787803105487,"version":"build-2784847793"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,10,24]],"date-time":"2006-10-24T00:00:00Z","timestamp":1161648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1186\/1750-1172-1-41","type":"journal-article","created":{"date-parts":[[2006,10,24]],"date-time":"2006-10-24T20:56:08Z","timestamp":1161723368000},"source":"Crossref","is-referenced-by-count":16,"title":["Primary sclerosing cholangitis"],"prefix":"10.1186","volume":"1","author":[{"given":"Joy","family":"Worthington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,10,24]]},"reference":[{"key":"41_CR1","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1136\/gut.38.4.610","volume":"38","author":"U Broome","year":"1996","unstructured":"Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, Prytz H, Sandberg-Gertzen H, Wallerstedt S, Lindberg G: Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996, 38: 610-615.","journal-title":"Gut"},{"key":"41_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1053\/bega.2001.0212","volume":"15","author":"RH Wiesner","year":"2001","unstructured":"Wiesner RH: Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease. Best Pract Res Clin Gastroenterol. 2001, 15: 667-680. 10.1053\/bega.2001.0212.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"41_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/00365529850166284","volume":"33","author":"KM Boberg","year":"1998","unstructured":"Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H: Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol. 1998, 33: 99-103. 10.1080\/00365529850166284.","journal-title":"Scand J Gastroenterol"},{"key":"41_CR4","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1053\/j.gastro.2004.04.052","volume":"126","author":"JG Kingham","year":"2004","unstructured":"Kingham JG, Kochar N, Gravenor MB: Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom. Gastroenterology. 2004, 126: 1929-1930. 10.1053\/j.gastro.2004.04.052.","journal-title":"Gastroenterology"},{"key":"41_CR5","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","volume":"125","author":"K Bambha","year":"2003","unstructured":"Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, Loftus EV Jr, Yawn BP, Dickson ER, Melton LJ: Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology. 2003, 125: 1364-1369. 10.1016\/j.gastro.2003.07.011.","journal-title":"Gastroenterology"},{"key":"41_CR6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/hep.1840100406","volume":"10","author":"RH Wiesner","year":"1989","unstructured":"Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, Fleming TR, Fisher LD, Beaver SJ, LaRusso NF: Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology. 1989, 10: 430-436.","journal-title":"Hepatology"},{"key":"41_CR7","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","volume":"100","author":"JM Farrant","year":"1991","unstructured":"Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, Williams R: Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology. 1991, 100: 1710-1717.","journal-title":"Gastroenterology"},{"key":"41_CR8","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(91)90784-I","volume":"100","author":"R Olsson","year":"1991","unstructured":"Olsson R, Danielsson A, Jarnerot G, Lindstrom E, Loof L, Rolny P, Ryden BO, Tysk C, Wallerstedt S: Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology. 1991, 100: 1319-1323.","journal-title":"Gastroenterology"},{"key":"41_CR9","first-page":"503","volume":"52","author":"HA Shepherd","year":"1983","unstructured":"Shepherd HA, Selby WS, Chapman RW, Nolan D, Barbatis C, McGee JO, Jewell DP: Ulcerative colitis and persistent liver dysfunction. Q J Med. 1983, 52: 503-513.","journal-title":"Q J Med"},{"key":"41_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-2008-1040541","volume":"8","author":"E Schrumpf","year":"1988","unstructured":"Schrumpf E, Fausa O, Elgjo K, Kolmannskog F: Hepatobiliary complications of inflammatory bowel disease. Semin Liver Dis. 1988, 8: 201-219.","journal-title":"Semin Liver Dis"},{"key":"41_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/gut.2004.046615","volume":"54","author":"EV Loftus Jr","year":"2005","unstructured":"Loftus EV Jr, Harewood GC, Loftus CG, Tremaine WJ, Harmsen WS, Zinsmeister AR, Jewell DA, Sandborn WJ: PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005, 54: 91-96. 10.1136\/gut.2004.046615.","journal-title":"Gut"},{"key":"41_CR12","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1080\/003655202760373434","volume":"37","author":"KM Boberg","year":"2002","unstructured":"Boberg KM, Bergquist A, Mitchell S, Pares A, Rosina F, Broome U, Chapman R, Fausa O, Egeland T, Rocca G, Schrumpf E: Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol. 2002, 37: 1205-1211. 10.1080\/003655202760373434.","journal-title":"Scand J Gastroenterol"},{"key":"41_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1478-3231.1999.tb00083.x","volume":"19","author":"E Bjornsson","year":"1999","unstructured":"Bjornsson E, Kilander A, Olsson RCA: 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver. 1999, 19: 501-508.","journal-title":"Liver"},{"key":"41_CR14","first-page":"43","volume":"13","author":"J Ludwig","year":"1989","unstructured":"Ludwig J: Surgical pathology of the syndrome of primary sclerosing cholangitis. Am J Surg Pathol. 1989, 13: 43-49.","journal-title":"Am J Surg Pathol"},{"key":"41_CR15","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1111\/j.1572-0241.2000.03292.x","volume":"95","author":"S Saarinen","year":"2000","unstructured":"Saarinen S, Olerup O, Broome U: Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2000, 95: 3195-3199. 10.1111\/j.1572-0241.2000.03292.x.","journal-title":"Am J Gastroenterol"},{"key":"41_CR16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0168-8278(00)00060-X","volume":"34","author":"PJ Gow","year":"2001","unstructured":"Gow PJ, Fleming KA, Chapman RW: Primary sclerosing cholangitis associated with rheumatoid arthritis and HLA DR4: is the association a marker of patients with progressive liver disease?. J Hepatol. 2001, 34: 631-635. 10.1016\/S0168-8278(00)00060-X.","journal-title":"J Hepatol"},{"key":"41_CR17","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1136\/gut.33.10.1370","volume":"33","author":"SK Lo","year":"1992","unstructured":"Lo SK, Fleming KA, Chapman RW: Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. Gut. 1992, 33: 1370-1375.","journal-title":"Gut"},{"key":"41_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/bega.2001.0209","volume":"15","author":"B Terjung","year":"2001","unstructured":"Terjung B, Worman HJ: Anti-neutrophil antibodies in primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol. 2001, 15: 629-642. 10.1053\/bega.2001.0209.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"41_CR19","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/0016-5085(91)90657-7","volume":"100","author":"RH Duerr","year":"1991","unstructured":"Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F: Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides\/diarrheal illnesses. Gastroenterology. 1991, 100: 1590-1596.","journal-title":"Gastroenterology"},{"key":"41_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","volume":"359","author":"AJ Grant","year":"2002","unstructured":"Grant AJ, Lalor PF, Salmi M, Jalkanen S, Adams DH: Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease. Lancet. 2002, 359: 150-157. 10.1016\/S0140-6736(02)07374-9.","journal-title":"Lancet"},{"key":"41_CR21","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1136\/gut.2003.031732","volume":"53","author":"PT Donaldson","year":"2004","unstructured":"Donaldson PT: Genetics of liver disease: immunogenetics and disease pathogenesis. Gut. 2004, 53: 599-608. 10.1136\/gut.2003.031732.","journal-title":"Gut"},{"key":"41_CR22","first-page":"9","volume-title":"Primary sclerosing cholangitis","author":"JM Vierling","year":"1998","unstructured":"Vierling JM: Aetiopathogenesis of primary sclerosing cholangitis. Primary sclerosing cholangitis. Edited by: Manns PCR, Stieihl A, Wiesner R. London: Kluwer Academic Publishers; 1998:9"},{"key":"41_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/gut.51.4.567","volume":"51","author":"SA Mitchell","year":"2002","unstructured":"Mitchell SA, Thyssen M, Orchard TR, Jewell DP, Fleming KA, Chapman RW: Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study. Gut. 2002, 51: 567-573. 10.1136\/gut.51.4.567.","journal-title":"Gut"},{"key":"41_CR24","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1053\/gast.1996.v110.pm8613056","volume":"110","author":"KJ van Erpecum","year":"1996","unstructured":"van Erpecum KJ, Smits SJ, van de Meeberg PC, Linn FH, Wolfhagen FH, vanBerge-Henegouwen GP, Algra A: Risk of primary sclerosing cholangitis is associated with nonsmoking behavior. Gastroenterology. 1996, 110: 1503-1506. 10.1053\/gast.1996.v110.pm8613056.","journal-title":"Gastroenterology"},{"key":"41_CR25","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1053\/gast.1996.v110.pm8613055","volume":"110","author":"EV Loftus Jr","year":"1996","unstructured":"Loftus EV Jr, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP, Melton LJ: Primary sclerosing cholangitis is associated with nonsmoking: a case-control study. Gastroenterology. 1996, 110: 1496-502. 10.1053\/gast.1996.v110.pm8613055.","journal-title":"Gastroenterology"},{"key":"41_CR26","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1136\/gut.2003.036483","volume":"53","author":"TH Florin","year":"2004","unstructured":"Florin TH, Pandeya N, Radford-Smith GL: Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases. Gut. 2004, 53: 973-979. 10.1136\/gut.2003.036483.","journal-title":"Gut"},{"key":"41_CR27","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1053\/gast.2001.27965","volume":"121","author":"SA Mitchell","year":"2001","unstructured":"Mitchell SA, Bansi DS, Hunt N, Von Bergmann K, Fleming KA, Chapman RW: A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology. 2001, 121: 900-907. 10.1053\/gast.2001.27965.","journal-title":"Gastroenterology"},{"key":"41_CR28","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1111\/j.1572-0241.2001.03777.x","volume":"96","author":"DM Harnois","year":"2001","unstructured":"Harnois DM, Angulo P, Jorgensen RA, Larusso NF, Lindor KD: High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis. Am J Gastroenterology. 2001, 96: 1558-1562. 10.1111\/j.1572-0241.2001.03777.x.","journal-title":"Am J Gastroenterology"},{"key":"41_CR29","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","volume":"129","author":"R Olsson","year":"2005","unstructured":"Olsson R, Boberg KM, de Muckadell OS, Lindgren S, Hultcrantz R, Folvik G, Bell H, Gangsoy-Kristiansen M, Matre J, Rydning A, Wikman O, Danielsson A, Sandberg-Gertzen H, Ung KA, Eriksson A, Loof L, Prytz H, Marschall HU, Broome U: High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology. 2005, 129: 1464-1472. 10.1053\/j.gastro.2005.08.017.","journal-title":"Gastroenterology"},{"key":"41_CR30","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/0270-9139(95)90146-9","volume":"22","author":"M Wilschanski","year":"1995","unstructured":"Wilschanski M, Chait P, Wade JA, Davis L, Corey M, St Louis P, Griffiths AM, Blendis LM, Moroz SP, Scully L, et al: Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis. Hepatology. 1995, 22: 1415-1422. 10.1016\/0270-9139(95)90146-9.","journal-title":"Hepatology"},{"key":"41_CR31","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1572-0241.1998.224_a.x","volume":"93","author":"AN McNair","year":"1998","unstructured":"McNair AN, Moloney M, Portmann BC, Williams R, McFarlane IG: Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases. Am J Gastroenterol. 1998, 93: 777-784. 10.1111\/j.1572-0241.1998.224_a.x.","journal-title":"Am J Gastroenterol"},{"key":"41_CR32","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1053\/jhep.2001.22131","volume":"33","author":"GV Gregorio","year":"2001","unstructured":"Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D, Mieli-Vergani G: Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology. 2001, 33: 544-553. 10.1053\/jhep.2001.22131.","journal-title":"Hepatology"},{"key":"41_CR33","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1136\/gut.41.4.522","volume":"41","author":"D Kornfeld","year":"1997","unstructured":"Kornfeld D, Ekbom A, Ihre T: Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut. 1997, 41: 522-525.","journal-title":"Gut"},{"key":"41_CR34","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1053\/gast.2003.50156","volume":"124","author":"DS Pardi","year":"2003","unstructured":"Pardi DS, Loftus EV Jr, Kremers WK, Keach J, Lindor KD: Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology. 2003, 124: 889-893. 10.1053\/gast.2003.50156.","journal-title":"Gastroenterology"},{"key":"41_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","volume":"134","author":"BY Tung","year":"2001","unstructured":"Tung BY, Emond MJ, Haggitt RC, Bronner MP, Kimmey MB, Kowdley KV, Brentnall TA: Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med. 2001, 134: 89-95.","journal-title":"Ann Intern Med"},{"key":"41_CR36","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jhep.2004.01.002","volume":"40","author":"B Brandsaeter","year":"2004","unstructured":"Brandsaeter B, Isoniemi H, Broome U, Olausson M, Backman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Hockerstedt K, Makisalo H, Kirkegaard P, Friman S, Bjoro K: Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol. 2004, 40: 815-822. 10.1016\/j.jhep.2004.01.002.","journal-title":"J Hepatol"},{"key":"41_CR37","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","volume":"36","author":"A Bergquist","year":"2002","unstructured":"Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, Danielsson A, Hultcrantz R, Lindgren S, Prytz H, Sandberg-Gertzen H, Almer S, Granath F, Broome U: Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol. 2002, 36: 321-327. 10.1016\/S0168-8278(01)00288-4.","journal-title":"J Hepatol"},{"key":"41_CR38","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1055\/s-2002-35298","volume":"34","author":"B Lindberg","year":"2002","unstructured":"Lindberg B, Arnelo U, Bergquist A, Thorne A, Hjerpe A, Granqvist S, Hansson LO, Tribukait B, Persson B, Broome U: Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. Endoscopy. 2002, 34: 909-916. 10.1055\/s-2002-35298.","journal-title":"Endoscopy"},{"key":"41_CR39","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1002\/cncr.20469","volume":"101","author":"J Koopmann","year":"2004","unstructured":"Koopmann J, Thuluvath PJ, Zahurak ML, Kristiansen TZ, Pandey A, Schulick R, Argani P, Hidalgo M, Iacobelli S, Goggins M, Maitra A: Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma. Cancer. 2004, 101: 1609-1615. 10.1002\/cncr.20469.","journal-title":"Cancer"},{"key":"41_CR40","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1055\/s-1999-18","volume":"31","author":"CY Ponsioen","year":"1999","unstructured":"Ponsioen CY, Vrouenraets SM, van Milligen de Wit AW, Sturm P, Tascilar M, Offerhaus GJ, Prins M, Huibregtse K, Tytgat GN: Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy. 1999, 31: 305-309. 10.1055\/s-1999-18.","journal-title":"Endoscopy"},{"key":"41_CR41","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/gast.1997.v113.pm9322521","volume":"113","author":"FH Wolfhagen","year":"1997","unstructured":"Wolfhagen FH, Sternieri E, Hop WC, Vitale G, Bertolotti M, Van Buuren HR: Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology. 1997, 113: 1264-1269. 10.1053\/gast.1997.v113.pm9322521.","journal-title":"Gastroenterology"},{"key":"41_CR42","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1440-1746.1993.tb01510.x","volume":"8","author":"DA Gillespie","year":"1993","unstructured":"Gillespie DA, Vickers CR: Pruritus and cholestasis: therapeutic options. J Gastroenterol Hepatol. 1993, 8: 168-173.","journal-title":"J Gastroenterol Hepatol"},{"key":"41_CR43","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/j.1572-0241.2004.30204.x","volume":"99","author":"A Pares","year":"2004","unstructured":"Pares A, Cisneros L, Salmeron JM, Caballeria L, Mas A, Torras A, Rodes J: Extracorporeal albumin dialysis: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol. 2004, 99: 1105-1110. 10.1111\/j.1572-0241.2004.30204.x.","journal-title":"Am J Gastroenterol"},{"key":"41_CR44","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1572-0241.2004.04106.x","volume":"99","author":"E Bjornsson","year":"2004","unstructured":"Bjornsson E, Lindqvist-Ottosson J, Asztely M, Olsson R: Dominant strictures in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2004, 99: 502-508. 10.1111\/j.1572-0241.2004.04106.x.","journal-title":"Am J Gastroenterol"},{"key":"41_CR45","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/hep.510300501","volume":"30","author":"IW Graziadei","year":"1999","unstructured":"Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Hay JE, Charlton MR, Poterucha JJ, Rosen CB, Gores GJ, LaRusso NF, Krom RA: Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology. 1999, 30: 1121-1127. 10.1002\/hep.510300501.","journal-title":"Hepatology"},{"key":"41_CR46","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1080\/00365520310006009","volume":"38","author":"B Brandsaeter","year":"2003","unstructured":"Brandsaeter B, Friman S, Broome U, Isoniemi H, Olausson M, Backman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Hockerstedt K, Makisalo H, Kirkegaard P, Bjoro K: Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries. Scand J Gastroenterol. 2003, 38: 1176-1183. 10.1080\/00365520310006009.","journal-title":"Scand J Gastroenterol"},{"key":"41_CR47","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/00000658-199705000-00004","volume":"225","author":"JA Goss","year":"1997","unstructured":"Goss JA, Shackleton CR, Farmer DG, Arnaout WS, Seu P, Markowitz JS, Martin P, Stribling RJ, Goldstein LI, Busuttil RW: Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg. 1997, 225: 472-481. 10.1097\/00000658-199705000-00004.","journal-title":"Ann Surg"},{"key":"41_CR48","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/00001574-200405000-00013","volume":"20","author":"GR Macfaul","year":"2004","unstructured":"Macfaul GR, Chapman RW: Sclerosing cholangitis. Curr Opin Gastroenterol. 2004, 20: 275-280. 10.1097\/00001574-200405000-00013.","journal-title":"Curr Opin Gastroenterol"},{"key":"41_CR49","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/0016-5085(90)91096-O","volume":"98","author":"MK Porayko","year":"1990","unstructured":"Porayko MK, Wiesner RH, LaRusso NF, Ludwig J, MacCarty RL, Steiner BL, Twomey CK, Zinsmeister AR: Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology. 1990, 98: 1594-1602.","journal-title":"Gastroenterology"},{"key":"41_CR50","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3109\/00365529409092504","volume":"29","author":"KM Boberg","year":"1994","unstructured":"Boberg KM, Schrumpf E, Fausa O, Elgjo K, Kolmannskog F, Haaland T, Holter E: Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis. Scand J Gastroenterol. 1994, 29: 744-752.","journal-title":"Scand J Gastroenterol"},{"key":"41_CR51","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","volume":"5","author":"P Angulo","year":"2002","unstructured":"Angulo P, Maor-Kendler Y, Lindor KD: Small-duct primary sclerosing cholangitis: a long-term follow-up study. Hepatology. 2002, 5: 1494-1500. 10.1053\/jhep.2002.33202.","journal-title":"Hepatology"},{"key":"41_CR52","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1136\/gut.51.5.731","volume":"51","author":"E Bjornsson","year":"2002","unstructured":"Bjornsson E, Boberg KM, Cullen S, Fleming K, Clausen OP, Fausa O, Schrumpf E, Chapman RW: Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut. 2002, 51: 731-735. 10.1136\/gut.51.5.731.","journal-title":"Gut"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-1-41.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1750-1172-1-41\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-1-41.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T21:16:26Z","timestamp":1548191786000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-1-41"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,24]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["41"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-1-41","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,24]]},"article-number":"41"}}